Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Sofosbuvir/Ledipasvir in Iranian HCV Genotype 1 Patients
NCT03061032Phase 3Unknown
- Sponsor
- Iran Hepatitis Network
- Start
- Mar 2017
- Primary completion
- Dec 2018
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
A Phase 3 trial of Harvoni in hepatitis C (HCV), sponsored by Iran Hepatitis Network. Status: unknown.
02
Drugs
Harvoni
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03061032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03061032.